Accelerated clearance of polyethylene glycol-modified proteins by anti-polyethylene glycol IgM

Bioconjugate Chemistry

Volumn 10, Issue 3, 1999, Pages 520-528

  Cheng, Tian Lu ^a   Wu, Pin Yi ^a   Wu, Ming Fang ^a   Chern, Ji Wang ^a   Roffler, Steve R ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CHEMICAL ACTIVATION; ENZYMES; MAMMALS; MONOCLONAL ANTIBODIES; POLYETHYLENES; TUMORS;

ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCURONIDASE; GLUCURONIDES; MODIFIED PROTEINS; PRODRUG ACTIVATION; PRODRUGS; SERUM CONCENTRATION; SIDE EFFECT; TUMOR THERAPY; TUMOUR CELLS;

POLYETHYLENE GLYCOLS;

ANIMALIA;

EID: 0033136959     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc980143z     Document Type: Article

References (48)

1. Beatty, J. D., Beatty, B. G., and Vlahos, W. G. (1987) Measurement of monoclonal antibody affinity by noncompetitive enzyme immunoassay. J. Immunol. Methods 100, 173-179.
2. Begent, R. H. J., Ledermann, J. A., Green, A. J., Bagshawe, K. D., Riggs, S. J., Searle, F., Keep, P. A., Adam, T., Dale, R. G., and Glaser, M. G. (1989) Antibody distribution and dosimetry in patients receiving radiolabeled antibody therapy for colorectal cancer. Br. J. Cancer 60, 406-412.
3. Bradwell, A. R., Vaughan, A., Fairweather, D. S., and Dykes, P. W. (1983) Improved radioimmunodetection of tumours using second antibody. Lancet i, 247.
4. Chen, B. M., Chan, L. Y., Wang, S. M., Wu, M. F., Chern, J. W., and Roffler, S. R. (1997) Cure of malignant ascites and generation of protective immunity by monoclonal antibody-targeted activation of a glucuronide prodrug in rats. Int. J. Cancer 73, 392-402.
5. Cheng, T. L., Chen, B. M., Chan, L. Y., Wu, P. Y., Chern, J. W., and Roffler, S. R. (1997) Poly(ethylene glycol) modification of β-glucuronidase-antibody conjugates for solid-tumor therapy by targeted activation of glucuronide prodrugs. Cancer Immunol. Immunother. 44, 305-315.
6. Ciechanover, A., Schwartz, A. L., and Lodish, H. F. (1983) The asialoglycoprotein receptor internalizes and recycles independently of the transferrin and insulin receptors. Cell 32, 267-275.
7. Day, J. F., Thornburg, R. W., Thorpe, S. R., and Baynes, J. W. (1980) Carbohydrate-mediated clearance of antibody -antigen complexes from the circulation. The role of high mannose oligosaccharides in the hepatic uptake of IgM-antigen complexes. J. Biol. Chem. 255, 2360-2365.
8. Delgado, C., Francis, G. E., and Fisher, D. (1992) The uses and properties of PEG-linked proteins. Crit. Rev. Therapeut. Drug Carr. Systems 9, 249-304.
9. Fujimori, K., Covell, D. G., Fletcher, J. E., and Weinstein, J. N. (1990) A modeling analysis of monoclonal antibody percolation through tumors: a binding-site barrier. J. Nucl. Med. 31, 1191-1198.
10. Geuze, H. J., Slot, J. W., Strous, G. J., Lodish, H. F., and Schwartz, A. L. (1983) Intracellular site of asialoglycoprotein receptor-ligand uncoupling: double-label immunoelectron microscopy during receptor-mediated endocytosis. Cell 32, 277-287.
11. Goldenberg, D. M., Sharkey, R. M., and Ford, E. (1987) Anti-antibody enhancement of iodine-131 anti-CEA radioimmunodetection in experimental and clinical studies. J. Nucl. Med. 28, 1604-1610.
12. Guilarte, T. R. (1985) Radiometric-microbiological assay of biotin in human plasma. Ann. N. Y. Acad. Sci. 447, 398-399.
13. Habeeb, A. (1966) Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal. Biochem. 14, 328-336.
14. Haisma, H. J., Van-Muijen, M., Scheffer, G., Scheper, R. J., Pinedo, H. M., and Boven, E. (1995) A monoclonal antibody against human beta-glucuronidase for application in antibody-directed enzyme prodrug therapy. Hybridoma 14, 377-382.
15. Ishikawa, E., Hashida, S., Kohno, T., and Ohtaki, S. (1987) Modification of monoclonal antibodies with enzymes, biotin, and fluorochromes and their applications. Monoclonal Antibody Production Techniques and Applications (L. B. Schook, Ed.) pp 113-139, Marcel Dekker, Inc., New York.
16. Kerr, D. E., Garrigues, U. S., Wallace, P. M., Hellström, K. E., Hellström, I., and Senter, P. D. (1993) Application of monoclonal antibodies against cytosine deaminase for the in vivo clearance of a cytosine deaminase immunoconjugate. Bioconjugate Chem. 4, 353-357.
17. Klibanov, A. L., Martynov, A. V., Slinkin, M. A., Sakharov, I. Y., Smirnov, M. D., Muzykantov, V. R., Danilov, S. M., and Torchilin, V. P. (1988) Blood clearance of radiolabeled antibody: enhancement by lactosamination and treatment with biotin-avidin or anti-mouse antibodies. J. Nucl. Med. 29, 1951-1956.
18. Kobayashi, H., Sakahara, H., Endo, K., Hosono, M., Yao, Z. S., Toyama, S., and Konishi, J. (1995) Comparison of the chase effects of avidin, streptavidin, neutravidin, and avidin-ferritin on a radiolabeled biotinylated antitumor monoclonal antibody. Jpn. J. Cancer Res. 86, 310-314.
19. Lee, Y. C., Townsend, M. R., Hardy, J., Lönngren, J., Arnarp, M., Haraldsson, M., and Lönn, H. (1983) Binding of synthetic oligosaccharides to the hepatic Gal/GalNAc lectin. Dependence on fine structural features. J. Biol. Chem. 258, 199-202.
20. Lodish, H. F. (1991) Recognition of complex oligosaccharides by the multi-subunit asialoglycoprotein receptor. Trends Biol. Sci. 16, 374-377.
21. Maloney, D. G., Kaminski, M. S., Burowski, D., Haimovich, J., and Levy, R. (1985) Monoclonal anti-idiotype antibodies against the murine B cell lymphoma 38C13: Characterization and use as probes for the biology of the tumor in vivo and in vitro. Hybridoma 4, 191-209.
22. 2 fragments of an anti-tumour antibody. Br. J. Cancer 71, 18-24.
23. Martin, J., Stribbling, S. M., Poon, G. K., Begent, R. H., Napier, M., Sharma, S. K., and Springer, C. J. (1997) Antibody-directed enzyme prodrug therapy: pharmacokinetic and plasma levels of prodrug and drug in a phase I clinical trail. Cancer Chemother. Pharmacol. 40, 189-201.
24. Mattes, M. J. (1987) Biodistribution of antibodies after intraperitoneal or intravenous injection and effect of carbohydrate modifications. J. Natl. Cancer Inst. 79, 855-863.
25. Nishikawa, M., Miyazaki, C., Yamashita, F., Takakura, Y., and Hashida, M. (1995) Galactosylated proteins are recognized by the liver according to the surface density of galactose moieties. Am. J. Physiol. 268, G849-G856.
26. Ong, G. L., Ettenson, D., Sharkey, R. M., Marks, A., Baumal, R., Goldenberg, D. M., and Mattes, M. J. (1991) Galactose-conjugated antibodies in cancer therapy: properties and principles of action. Cancer Res. 51, 1619-26.
27. Pedley, R. B., Dale, R., Boden, J. A., Begent, R. H. J., Keep, P. A., and Green, A. J. (1989) The effect of second antibody clearance on the distribution and dosimetry of radiolabeled anti-CEA antibody in a human colonic tumor xenograft model. Int. J. Cancer 43, 713-718.
28. Rice, K. G., Weisz, O. A., Barthel, T., Lee, R. T., and Lee, Y. C. (1990) Defined geometry of binding between triantennary glycopeptides and the asialoglycoprotein receptor of rat hepatocytes. J. Biol. Chem 265, 18429-18434.
29. Roffler, S. R., Wang, S. M., Chern, J. W., Yeh, M. Y., and Tung, E. (1991) Anti-neoplastic glucuronide prodrug treatment of human tumor cells targeted with a monoclonal antibody-enzyme conjugate. Biochem. Pharmacol. 42, 2062-2065.
30. Roffler, S. R., Chan, J., and Yeh, M. Y. (1994) Potentiation of radioimmunotherapy by inhibition of topoisomerase I. Cancer Res. 54, 1276-1285.
31. Rogers, G. T., Burke, P. J., Sharma, S. K., Koodie, R., and Boden, J. A. (1995) Plasma clearance of an antibody-enzyme conjugate in ADEPT by monoclonal anti-enzyme: its effect on prodrug activation in vivo. Br. J. Cancer 72, 1357-1363.
32. Roit, I., Brostoff, J., and Male, D. (1989) Immunology, pp 21.5-21.9, Gower Medical Publishing, London.
33. Sharkey, R. M., Primus, F. J., and Goldenberg, D. M. (1984) Second antibody clearance of radiolabeled antibody in cancer radioimmunodetection. Proc. Natl. Acad. Sci. U.S.A. 81, 2843-2846.
34. Sharkey, R. M., Boerman, O. C., Natale, A., Pawlyk, D., Monestier, M., Losman, M. J., and Goldenberg, D. M. (1992) Enhanced clearance of radiolabeled murine monoclonal antibody by a synegeic anti-idiotype antibody in tumor-bearing nude mice. Int. J. Cancer 51, 266-273.
35. Sharma, S. K., Bagshawe, K. D., Burke, P. J., Boden, R. W., and Rogers, G. T. (1990) Inactivation and clearance of an anti-CEA carboxypeptidase G2 conjugate in blood after localization in a xenograft model. Br. J. Cancer 61, 659-662.
36. Sharma, S. K., Bagshawe, K. D., Burke, P. J., Boden, J. A., Rogers, G. T., Springer, C. J., Melton, R. G., and Sherwood, R. F. (1994) Galactosylated antibodies and antibody-enzyme conjugates in antibody-directed enzyme prodrug therapy. Cancer 73, 1114-20.
37. Stella, M., DeNardo, P., Paganelli, G., Magnani, P., Mangili, F., Sassi, I., Baratti, D., Gini, P., Zito, F., and Cristallo, M. (1994) Avidin-biotin system in radioimmunoguided surgery for colorectal cancer. Advantages and limits. Dis. Colon Rectum 37, 335-343.
38. Stocks, S. J., Jones, A. J. M., Ramey, C. W., and Brooks, D. E. (1986) A fluorometric assay of the degree of modification of protein primary amines with poly(ethylene glycol). Anal. Biochem. 154, 232-234.
39. Thornburg, R. W., Day, J. F., Baynes, J. W., and Thorpe, S. R. (1980) Carbohydrate-mediated clearance of immune complexes from the circulation. A role for galactose residues in the hepatic uptake of IgG-antigen complexes. J. Biol. Chem. 255, 6820-6825.
40. Thomas, G. D., Chappell, M. J., Dykes, P. W., Ramsden, D. B., Godfrey, K. R., Ellis, J. R. M., and Bradwell, A. R. (1989) Effect of dose, molecular size. affinity, and protein binding on tumor uptake of antibody or ligand: A mathematical model. Cancer Res. 49, 3290-3296.
41. Townsend, R. R., Hardy, M. R., Wong, T. C., and Lee, Y. C. (1986) Binding of N-linked bovine fetuin glycopeptides to isolated rabbit hepatocytes: Gal/GalNAc hepatic lectin discrimination between Galβ(1,4)GalNAc and Galβ(1,3)GalNAc in a triantennary structure. Biochemistry 25, 5716-5725.
42. Wallace, P. M., MacMaster, J. F., Smith, V. F., Kerr, D. E., Senter, P. D., and Cosand, W. L. (1994) Intratumoral generation of 5-fluorouracil mediated by an antibody-cytosine deaminase conjugate in combination with 5-fluorocytosine. Cancer Res. 54, 2719-2723.
43. Wang, S. M., Chern, J. W., Yeh, M. Y., Ng, J. C., Tung, E., and Roffler, S. R. (1992) Specific activation of glucuronide prodrugs by antibody-targeted enzyme conjugates for cancer therapy. Cancer Res. 52, 4484-4491.
44. Wolf, B., Hymes, J., and Heard, G. S. (1990) Biotinidase. Methods Enzymol. 184, 103-111.
45. Yao, Z., Zhang, M., Kobayashi, H., Sakahara, H., Nakada, H., Yamashina, I., and Konishi, J. (1995) Improved targeting of radiolabeled streptavidin in tumors pretargeted with biotinylated monoclonal antibodies through an avidin chase. J. Nucl. Med. 36, 837-841.
46. Yeh, M. Y, Hellström, I., Brown, J. P., Warner, G. A., Hansen, J. A., and Hellström, K. E. (1979) Cell surface antigens of human melanoma identified by monoclonal antibody. Proc. Natl. Acad. Sci. U.S.A. 76, 2927-1931.
47. Yeh, M. Y., Roffler, S. R., and Yu, M. H. (1992) Doxorubicin-monoclonal antibody conjugate for therapy of human cervical carcinoma. Int. J. Cancer 51, 274-282.
48. Zhang, M., Sakahara, H., Yao, Z., Saga, T., Nakamoto, Y., Sato, N., Nakada, H., Yamashina, I., and Konishi, J. (1997) Intravenous avidin chase improved localization of radiolabeled streptavidin in intraperitoneal xenograft pretargeted with biotinylated antibody. Nucl. Med. Biol. 24, 61-64.